A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

Bioengineering aims to improve targeted cancer therapies by enhancing drug delivery, boosting immune responses, and refining surgical techniques. The field is highly interdisciplinary, merging ...

Lung cancer in never-smokers exhibits distinct biological characteristics, often leading to late-stage diagnoses due to lack of screening. Targeted therapies, guided by molecular testing, offer ...

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

In recent years, cancer immunotherapy has transformed the treatment landscape for a wide range of malignancies, offering ...

Neutropenia, anemia, and thrombocytopenia are common hematologic toxicities associated with ADCs. The most common cytopenia associated with T-DXd is neutropenia. In the DESTINY-Breast03 trial, ...

A $10 million grant by retired biotechnology leader and trustee board member Henri A. Termeer will help Massachusetts General Hospital in Boston build the Henri and Belinda Termeer Center for Targeted ...

Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).

This review highlights the potential of natural polysaccharide microneedles in cancer immunotherapy, focusing on localized ...